14G2a / 14.G2a

Antibody IDAN0157
Epitope ID EP0061
Epitope nameGD2
Recognition regionGalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer
Immunoprecipitation
Immunoblot[2][3][1]
ELISA/RIA[1]
Flow cytometry
Histochemistry[4][5][6][1]
Comment
SpeciesMouse
CategoryMonoclonal
IsotypeIgG2a
Immunogen
AvailabilityBecton, Dickinson and Company
Santa Cruz Biotechnology, Inc.
Millipore
Applications
Up  Down
1 Ravindranath MH, Muthugounder S, Presser N, Selvan SR, Portoukalian J, Brosman S, Morton DL.
Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer.
Biochem Biophys Res Commun. 2004 Nov 5;324(1):154-65
PMID: 15464996
2 Sen G, Chakraborty M, Foon KA, Reisfeld RA, Bhattacharya-Chatterjee M.
Preclinical evaluation in nonhuman primates of murine monoclonal anti-idiotype antibody that mimics the disialoganglioside GD2.
Clin Cancer Res. 1997 Nov ;3(11):1969-76
PMID: 9815586
3 Sen G, Chakraborty M, Foon KA, Reisfeld RA, Bhattacharya-Chatterjee MB.
Induction of IgG antibodies by an anti-idiotype antibody mimicking disialoganglioside GD2.
J Immunother. 1998 Jan ;21(1):75-83
PMID: 9456440
4 Lode HN, Handgretinger R, Schuermann U, Seitz G, Klingebiel T, Niethammer D, Beck J.
Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry.
Eur J Cancer. 1997 Oct ;33(12):2024-30
PMID: 9516847
5 Vriesendorp FJ, Quadri SM, Flynn RE, Malone MR, Cromeens DM, Stephens LC, Vriesendorp HM.
Preclinical analysis of radiolabeled anti-GD2 immunoglobulin G.
Cancer. 1997 Dec 15;80(12 Suppl):2642-9
PMID: 9406719
6 Yuki N, Yamada M, Tagawa Y, Takahashi H, Handa S.
Pathogenesis of the neurotoxicity caused by anti-GD2 antibody therapy.
J Neurol Sci. 1997 Aug ;149(2):127-30
PMID: 9171318